Epigenetic repression of CCDC37 and MAP1B links chronic obstructive pulmonary disease to lung cancer

Journal of Thoracic Oncology

Volumn 10, Issue 8, 2015, Pages 1181-1188

  Tessema, Mathewos ^a   Yingling, Christin M ^a   Picchi, Maria A ^a   Wu, Guodong ^a   Liu, Yushi ^a,b   Weissfeld, Joel L ^b   Siegfried, Jill M ^c   Tesfaigzi, Yohannes ^a   Belinsky, Steven A ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

COPD; EWAS; Methylation; NSCLC; Sputum.

Indexed keywords

BIOLOGICAL MARKER; COILED COIL DOMAIN CONTAINING PROTEIN 37; COMPLEMENTARY DNA; DNA; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 5; UNCLASSIFIED DRUG; MAP1B PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETIC REPRESSION; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROMOTER REGION; SMOKING; ADENOCARCINOMA; CHEMISTRY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; LUNG; LUNG TUMOR; MIDDLE AGED; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DNA METHYLATION; EPIGENETIC REPRESSION; FEMALE; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84942877073     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000592     Document Type: Article

References (43)

1. Punturieri A, Szabo E, Croxton TL, Shapiro SD, Dubinett SM. Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J Natl Cancer Inst 2009;101:554-559.
2. Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep 2013;61:1-117.
3. Houghton AM. Mechanistic links between COPD and lung cancer. Nat Rev Cancer 2013;13:233-245.
4. Nakayama M, Satoh H, Sekizawa K. Risk of cancers in COPD patients. Chest 2003;123:1775-1776.
5. Papi A, Casoni G, Caramori G, et al. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax 2004;59:679-681.
6. Belinsky SA. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 2004;4:707-717.
7. Tellez CS, Juri DE, Do K, et al. EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. Cancer Res 2011;71:3087-3097.
8. Belinsky SA, Nikula KJ, Palmisano WA, et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A 1998;95:11891-11896.
9. Belinsky SA, Palmisano WA, Gilliland FD, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 2002;62:2370-2377.
10. Sood A, Petersen H, Blanchette CM, et al. Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers. Am J Respir Crit Care Med 2010;182:1098-1104.
11. Suzuki M, Wada H, Yoshino M, et al. Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling. Ann Surg Oncol 2010;17:878-888.
12. Bibikova M, Barnes B, Tsan C, et al. High density DNA methylation array with single CpG site resolution. Genomics 2011;98:288-295.
13. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276.
14. Hunninghake GM, Cho MH, Tesfaigzi Y, et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med 2009;361:2599-2608.
15. Leng S, Liu Y, Thomas CL, et al. Native American ancestry affects the risk for gene methylation in the lungs of Hispanic smokers from New Mexico. Am J Respir Crit Care Med 2013;188:1110-1116.
16. Leng S, Stidley CA, Liu Y, et al. Genetic determinants for promoter hypermethylation in the lungs of smokers: a candidate gene-based study. Cancer Res 2012;72:707-715.
17. Leng S, Stidley CA, Willink R, et al. Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation. Cancer Res 2008;68:3049-3056.
18. Wilson DO, Weissfeld JL, Fuhrman CR, et al. The Pittsburgh lung screening study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008;178:956-961.
19. Ramirez RD, Sheridan S, Girard L, et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 2004;64:9027-9034.
20. Belinsky SA, Liechty KC, Gentry FD, et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 2006;66:3338-3344.
21. Tessema M, Willink R, Do K, et al. Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25. Cancer Res 2008;68:1707-1714.
22. Tessema M, Yu YY, Stidley CA, et al. Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers. Carcinogenesis 2009;30:1132-1138.
23. Tessema M, Klinge DM, Yingling CM, et al. Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. Oncogene 2010;29:5159-5170.
24. Tessema M, Yingling CM, Liu Y, et al. Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers. Carcinogenesis 2014;35:1248-1257.
25. Tessema M, Yingling CM, Thomas CL, et al. SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15. Oncogene 2012;31:4107-4116.
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001;25:402-408.
27. Siegmund KD. Statistical approaches for the analysis of DNA methylation microarray data. Hum Genet 2011;129:585-595.
28. Clark SJ, Melki J. DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene 2002;21:5380-5387.
29. Ferracin M, Gaf R, Miotto E, et al. The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile. J Pathol 2008;214:594-602.
30. Kwon YJ, Lee SJ, Koh JS, et al. Genome-wide analysis of DNA methylation and the gene expression change in lung cancer. J Thorac Oncol 2012;7:20-33.
31. Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 2010;465:721-727.
32. Tessema M, Yingling CM, Grimes MJ, et al. Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers. PLoS One 2012;7:e34850.
33. Yamamoto R, Song K, Yanagisawa HA, et al. The MIA complex is a conserved and novel dynein regulator essential for normal ciliary motility. J Cell Biol 2013;201:263-278.
34. Cuozzo C, Porcellini A, Angrisano T, et al. DNA damage, homologydirected repair, and DNA methylation. PLoS Genet 2007;3:e110.
35. Benoist M, Palenzuela R, Rozas C, et al. MAP1B-dependent Rac activation is required for AMPA receptor endocytosis during long-term depression. EMBO J 2013;32:2287-2299.
36. Harrison B, Kraus M, Burch L, et al. DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing. J Biol Chem 2008;283:9999-10014.
37. Montenegro-Venegas C, Tortosa E, Rosso S, et al. MAP1B regulates axonal development by modulating Rho-GTPase Rac1 activity. Mol Biol Cell 2010;21:3518-3528.
38. Langkopf A, Hammarback JA, Mller R, Vallee RB, Garner CC. Microtubule-Associated proteins 1A and LC2. Two proteins encoded in one messenger RNA. J Biol Chem 1992;267:16561-16566.
39. Lee SY, Kim JW, Jeong MH, et al. Microtubule-Associated protein 1B light chain (MAP1B-LC1) negatively regulates the activity of tumor suppressor p53 in neuroblastoma cells. FEBS Lett 2008;582:2826-2832.
40. Lerch-Gaggl AF, Sun K, Duncan SA. Light chain 1 of microtubule-Associated protein 1B can negatively regulate the action of Pes1. J Biol Chem 2007;282:11308-11316.
41. Leng S, Do K, Yingling CM, et al. Defining a gene promoter methylation signature in sputum for lung cancer risk assessment. Clin Cancer Res 2012;18:3387-3395.
42. Leng S, Liu Y, Weissfeld JL, et al. 15q12 variants, sputum gene promoter hypermethylation, and lung cancer risk: a GWAS in smokers. J Natl Cancer Inst 2015;107(5): djv035 doi:10.1093/jnci/djv035.
43. Bruse S, Petersen H, Weissfeld J, et al. Increased methylation of lung cancer-Associated genes in sputum DNA of former smokers with chronic mucous hypersecretion. Respir Res 2014;15:2.